Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 5/21/2007


1.		Phase II and III Chemotherapy with 5-FU, CTX, TG, MeCCNU and TGDR for Advanced Colon and Rectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				no age specified				NCI				EST-4273

Last Modified: 4/1/1997


2.		Phase III Therapy with DNM, ARA-C, AZC, Beta-TGDR, TG & BCG for Induction, Consolidation & Maintenance of Acute Myelogenous Leukemia (Summary Last Modified 04/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over								SEG-77AML318 SEG-77AML0103


3.		Phase II Chemotherapy with AZC/TGDR for Acute Myelogenous and Lymphoblastic Leukemia, Blastic Phase & Chronic Granulocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 15								SEG-268


4.		Phase II Multi-Drug Chemotherapy, Splenectomy & Immunotherapy for Longterm Remission in Acute Myelogenous Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over								SEG-76PAML0102


5.		Phase II Chemotherapy with MeCCNU/TGDR vs MITO/TGDR vs MITO/5-FU for Refractory Disseminated Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-7634

Last Modified: 8/9/2006


6.		A Master Protocol for Phase II Chemotherapy for Advanced Pancreatic Carcinoma --- HMM, DAG, b-TGdR, ICRF-159

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								GITSG-9376A


7.		Phase II Chemotherapy Dose Schedules of B-2'-Deoxythioguanosine for Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Closed				over 15								SEG-248


8.		Phase II Induction and Maintenance with Beta-Deoxythioguanosine for Refractory Acute Leukemia in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Closed				under 21				NCI				CCG-081


9.		MeCCNU Plus TGDR, VP-16 and INOX Chemotherapy for Previously Treated Recurrent or Metastatic Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				no age specified				NCI				EST-1275

Last Modified: 12/13/2007


10.		Chemotherapy with 5-FU, MeCCNU, VCR, DTIC, HU and TGDR for Advanced Inoperable Colon and Rectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				no age specified				NCI				EST-4275

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute